Our investment thesis is simple. The world is decades behind in pandemic preparedness. We aim to fix that.
As early-stage, tech investors we look for U.S. based companies with defensible and scalable software, hardware, and deep tech solutions. In assessing these opportunities, we first look to our unifying investment themes.
Unifying Investment Themes
Investing in Scalable Solutions
The Fund typically invests in three types of companies within its investment framework:
In-market, successful startups with pandemic relevant offerings who are ready to scale their business and impact
In-market and successful startups focused on a different application who could easily adapt and scale their offerings to address pandemic challenges
Startups with defensible, scalable and somewhat validated solutions that can get to market faster with a small investment
Investment Thesis – What We’re Not
Not a Relief Fund
The Fund is not a “relief” fund. We don’t provide funding to distressed communities. In line with our investment thesis, we like companies that have truly innovative, differentiated, and defensible offerings. We look for huge market potential and the ability to deliver upper quartile returns. Visit our Portfolio page to view example companies.
Not Just Healthcare
The Pandemic Impact Fund invests well beyond healthcare. We seek opportunities that help:
- find pandemics faster such as surveillance, testing, GIS and population health
- fix it faster such as drug development platforms, medical devices for drug delivery, and telemedicine
- make work, work or life work for that matter, such as disinfection technologies, remote collaboration tools, teleconnection, robotics, cybersecurity, and EDtech
- do better next time such as supply chain, process and manufacturing resilience, communication, and food security.